These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16777495)

  • 1. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study.
    Rønne Hansen C; Pressler T; Høiby N; Gormsen M
    J Cyst Fibros; 2006 Dec; 5(4):245-51. PubMed ID: 16777495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis.
    Firmida MC; Pereira RH; Silva EA; Marques EA; Lopes AJ
    Braz J Med Biol Res; 2016; 49(4):e5097. PubMed ID: 26909788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
    Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
    J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
    Lobo LJ; Tulu Z; Aris RM; Noone PG
    Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achromobacter xylosoxidans infection in an adult cystic fibrosis unit in Madrid.
    Llorca Otero L; Girón Moreno R; Buendía Moreno B; Valenzuela C; Guiu Martínez A; Alarcón Cavero T
    Enferm Infecc Microbiol Clin; 2016 Mar; 34(3):184-7. PubMed ID: 26139304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data.
    Amoureux L; Bador J; Siebor E; Taillefumier N; Fanton A; Neuwirth C
    J Cyst Fibros; 2013 Mar; 12(2):170-6. PubMed ID: 22944724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.
    Lambiase A; Catania MR; Del Pezzo M; Rossano F; Terlizzi V; Sepe A; Raia V
    Eur J Clin Microbiol Infect Dis; 2011 Aug; 30(8):973-80. PubMed ID: 21279730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcaligenes infection in cystic fibrosis.
    Tan K; Conway SP; Brownlee KG; Etherington C; Peckham DG
    Pediatr Pulmonol; 2002 Aug; 34(2):101-4. PubMed ID: 12112775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
    Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe Achromobacter xylosoxidans infection and loss of sputum bacterial diversity in an adult patient with cystic fibrosis.
    Talbot NP; Flight WG
    Paediatr Respir Rev; 2016 Aug; 20 Suppl():27-9. PubMed ID: 27374622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.
    Waters V; Atenafu EG; Salazar JG; Lu A; Yau Y; Matukas L; Tullis E; Ratjen F
    J Cyst Fibros; 2012 Jan; 11(1):8-13. PubMed ID: 21849265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment.
    Ridderberg W; Bendstrup KE; Olesen HV; Jensen-Fangel S; Nørskov-Lauritsen N
    J Cyst Fibros; 2011 Dec; 10(6):466-9. PubMed ID: 21835703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive flow-to-volume dysanapsis in cystic fibrosis: a predictor for lung transplantation?
    Vilozni D; Lavie M; Sarouk I; Efrati O
    Am J Respir Crit Care Med; 2012 Jul; 186(1):82-7. PubMed ID: 22538801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.
    Edwards BD; Greysson-Wong J; Somayaji R; Waddell B; Whelan FJ; Storey DG; Rabin HR; Surette MG; Parkins MD
    J Clin Microbiol; 2017 Jul; 55(7):2074-2085. PubMed ID: 28446570
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.
    Cools P; Ho E; Vranckx K; Schelstraete P; Wurth B; Franckx H; Ieven G; Van Simaey L; Van Daele S; Verhulst S; De Baets F; Vaneechoutte M
    BMC Microbiol; 2016 Jun; 16(1):122. PubMed ID: 27342812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report.
    Hoyle N; Zhvaniya P; Balarjishvili N; Bolkvadze D; Nadareishvili L; Nizharadze D; Wittmann J; Rohde C; Kutateladze M
    Res Microbiol; 2018 Nov; 169(9):540-542. PubMed ID: 29777836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis.
    Dalbøge CS; Hansen CR; Pressler T; Høiby N; Johansen HK
    J Cyst Fibros; 2011 Sep; 10(5):318-25. PubMed ID: 21463972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients.
    Vanderhelst E; De Meirleir L; Verbanck S; Piérard D; Vincken W; Malfroot A
    J Cyst Fibros; 2012 Jan; 11(1):2-7. PubMed ID: 21907637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients.
    Raso T; Bianco O; Grosso B; Zucca M; Savoia D
    APMIS; 2008 Sep; 116(9):837-41. PubMed ID: 19024606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.